Search research articles
Contact Us
Filters
Showing results (311-320 of 527) with videos related to
Page
of 53
Sort By:
Cardiovascular Diabetology
|
April 21, 2012
Baseline comparison of three health utility measures and the feeling thermometer among participants in the Action to Control Cardiovascular Risk in Diabetes trial
Dennis W Raisch, Patricia Feeney, David C Goff, et al.
Contemporary Clinical Trials
|
September 18, 2009
Healthy Living Partnerships to Prevent Diabetes (HELP PD): design and methods
Jeffrey A Katula, Mara Z Vitolins, Erica L Rosenberger, et al.
Journal of Cardiopulmonary Rehabilitation and Prevention
|
March 8, 2014
Reliability of abstracting performance measures: results of the cardiac rehabilitation referral and reliability (CR3) project
Randal J Thomas, Jensen S Chiu, David C Goff, et al.
The Journal of Clinical Psychiatry
|
February 12, 2005
Medical morbidity and mortality in schizophrenia: guidelines for psychiatrists
Donald C Goff, Corinne Cather, A Eden Evins, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine
|
March 23, 2013
Reduction in observation unit length of stay with coronary computed tomography angiography depends on time of emergency department presentation
Simon A Mahler, Brian C Hiestand, Jamaji Nwanaji-Enwerem, et al.
BMC Health Services Research
|
May 3, 2013
Hospital laboratory reporting may be a barrier to detection of 'microsize' myocardial infarction in the US: an observational study
Monika M Safford, Gaurav Parmar, Codrin S Barasch, et al.
Contemporary Clinical Trials
|
October 13, 2006
Value of recruitment strategies used in a primary care practice-based trial
Shellie D Ellis, Alain G Bertoni, Denise E Bonds, et al.
Biological Psychiatry
|
October 8, 2015
ITI-007 for the Treatment of Schizophrenia: A 4-Week Randomized, Double-Blind, Controlled Trial
Jeffrey A Lieberman, Robert E Davis, Christoph U Correll, et al.
Biological Psychiatry
|
April 2, 2002
Modulation of brain and serum glutamatergic concentrations following a switch from conventional neuroleptics to olanzapine
Donald C Goff, John Hennen, In Kyoon Lyoo, et al.
Biological Psychiatry
|
July 21, 2000
Schizophrenic subjects show aberrant fMRI activation of dorsolateral prefrontal cortex and basal ganglia during working memory performance
D S Manoach, R L Gollub, E S Benson, et al.
Page
of 53
Search research articles
Search
Showing results (311-320 of 527) with videos related to
Sort By:
Page
of 53
Cardiovascular Diabetology
|
April 21, 2012
Baseline comparison of three health utility measures and the feeling thermometer among participants in the Action to Control Cardiovascular Risk in Diabetes trial
Dennis W Raisch, Patricia Feeney, David C Goff, et al.
Contemporary Clinical Trials
|
September 18, 2009
Healthy Living Partnerships to Prevent Diabetes (HELP PD): design and methods
Jeffrey A Katula, Mara Z Vitolins, Erica L Rosenberger, et al.
Journal of Cardiopulmonary Rehabilitation and Prevention
|
March 8, 2014
Reliability of abstracting performance measures: results of the cardiac rehabilitation referral and reliability (CR3) project
Randal J Thomas, Jensen S Chiu, David C Goff, et al.
The Journal of Clinical Psychiatry
|
February 12, 2005
Medical morbidity and mortality in schizophrenia: guidelines for psychiatrists
Donald C Goff, Corinne Cather, A Eden Evins, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine
|
March 23, 2013
Reduction in observation unit length of stay with coronary computed tomography angiography depends on time of emergency department presentation
Simon A Mahler, Brian C Hiestand, Jamaji Nwanaji-Enwerem, et al.
BMC Health Services Research
|
May 3, 2013
Hospital laboratory reporting may be a barrier to detection of 'microsize' myocardial infarction in the US: an observational study
Monika M Safford, Gaurav Parmar, Codrin S Barasch, et al.
Contemporary Clinical Trials
|
October 13, 2006
Value of recruitment strategies used in a primary care practice-based trial
Shellie D Ellis, Alain G Bertoni, Denise E Bonds, et al.
Biological Psychiatry
|
October 8, 2015
ITI-007 for the Treatment of Schizophrenia: A 4-Week Randomized, Double-Blind, Controlled Trial
Jeffrey A Lieberman, Robert E Davis, Christoph U Correll, et al.
Biological Psychiatry
|
April 2, 2002
Modulation of brain and serum glutamatergic concentrations following a switch from conventional neuroleptics to olanzapine
Donald C Goff, John Hennen, In Kyoon Lyoo, et al.
Biological Psychiatry
|
July 21, 2000
Schizophrenic subjects show aberrant fMRI activation of dorsolateral prefrontal cortex and basal ganglia during working memory performance
D S Manoach, R L Gollub, E S Benson, et al.
Page
of 53